Vaccine Power: Immune cells target cancerous tissue | Science News



Support credible science journalism.

Subscribe to Science News today.


Vaccine Power: Immune cells target cancerous tissue

10:04am, February 20, 2002

In its first test in people, a new vaccine shows signs of fighting prostate cancer in men who have the disease. The treatment enlists a person's own immune cells to attack prostate tissue, including cancerous tissue. Despite assaulting some healthy cells, the vaccine appears safe and potentially effective in people, say scientists at Duke University Medical Center in Durham, N.C.

Researchers have been developing vaccines against cancer for several decades, but progress has been slow (SN: 6/13/98, p. 380: Anticancer vaccines differ from most other vaccines by targeting tumors instead of microbes.

This article is available only to subscribing members. Join the Society today or Log in.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content